Overview

Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Trial to determine the safety, efficacy and tolerability of acamprosate for the treatment of cocaine dependence.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Acamprosate
Cocaine